Startups

Biotech startup Lantern Pharma's IPO yields $26 million for its cancer drug development


A Dallas biotechnology startup will hire more cancer researchers, biologists and artificial intelligence developers with the $26 million it raised in an …

To Read More, Please Visit Source

Related Articles

Back to top button
error: